株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

股関節再建:パイプライン分析

Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 341587
出版日 ページ情報 英文 227 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
股関節再建:パイプライン分析 Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月01日 ページ情報: 英文 227 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている股関節再建のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 股関節再建の概要

第3章 開発中の製品

  • 股関節再建 - 開発段階別のパイプライン製品
  • 股関節再建 - セグメント別のパイプライン製品
  • 股関節再建 - 国 (地域) 別のパイプライン製品
  • 股関節再建 - 規制別のパイプライン製品
  • 股関節再建 - 認証時期別 (推定) のパイプライン製品
  • 股関節再建 - 現在進行中の治験

第4章 股関節再建 - 開発中のパイプライン製品:企業別

  • 股関節再建企業 - 開発段階別のパイプライン製品
  • 股関節再建 - 開発段階別のパイプライン製品

第5章 股関節再建企業と製品の概要

  • Amedica Corporation
  • Bonovo Orthopedics, Inc.
  • Corentec Co., Ltd.
  • Corin Group Plc
  • DePuy Companies
  • Dimicron Inc.
  • Exactech, Inc.
  • Fortis Orthopedics
  • Fraunhofer Institute for Applied Polymer Research
  • Implants International Limited
  • INOR Orthopaedics
  • JRI Orthopaedics Ltd
  • 京セラメディカル
  • Limacorporate S.p.a.
  • MX Orthopedics, Corp.
  • Nano Interface Technology, Inc.
  • Naviswiss AG
  • OrthoGrid Systems
  • OrthoPediatrics Corp.
  • PLD Corporation Limited (Inactive)
  • PreSRV Ltd.
  • Renova Orthopedics, LLC
  • SAS HyPrevention
  • SINTEF
  • Stryker Corporation
  • Tech Manage Corp.
  • University of Alberta
  • University of South Florida
  • University of Warwick
  • Zimmer Biomet Holdings, Inc.

第6章 股関節再建 - 最近の動向

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0468EPD

GlobalData's Medical Devices sector report, "Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Hip Reconstruction Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hip Reconstruction Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 10

2 Introduction 11

  • 2.1 Hip Reconstruction Devices Overview 11

3 Products under Development 13

  • 3.1 Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
  • 3.2 Hip Reconstruction Devices - Pipeline Products by Segment 14
  • 3.3 Hip Reconstruction Devices - Pipeline Products by Territory 15
  • 3.4 Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
  • 3.5 Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
  • 3.6 Hip Reconstruction Devices - Ongoing Clinical Trials 18

4 Hip Reconstruction Devices - Pipeline Products under Development by Companies 19

  • 4.1 Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development 19
  • 4.2 Hip Reconstruction Devices - Pipeline Products by Stage of Development 21

5 Hip Reconstruction Devices Companies and Product Overview 23

  • 5.1 4-Web Spine, LLC Company Overview 23
  • 5.2 Amedica Corp Company Overview 24
  • 5.3 Arthromeda Inc Company Overview 25
  • 5.4 Biotechni SAS Company Overview 26
  • 5.5 Bonovo Orthopedics Inc Company Overview 28
  • 5.6 ConforMIS Inc Company Overview 30
  • 5.7 Corentec Co Ltd Company Overview 31
  • 5.8 DePuy Synthes Inc Company Overview 32
  • 5.9 Exactech Inc Company Overview 38
  • 5.10 Flexable Orthopedics Company Overview 42
  • 5.11 Fortis Orthopedics Company Overview 43
  • 5.12 Fraunhofer Institute for Applied Polymer Research Company Overview 44
  • 5.13 Hip Innovation Technology LLC Company Overview 45
  • 5.14 Implants International Ltd Company Overview 48
  • 5.15 Inor Medical Products Ltd Company Overview 49
  • 5.16 JRI Orthopaedics Ltd Company Overview 51
  • 5.17 KYOCERA Medical Corp Company Overview 64
  • 5.18 Limacorporate SpA Company Overview 65
  • 5.19 Metalicity Ltd Company Overview 67
  • 5.20 MicroPort Scientific Corp Company Overview 68
  • 5.21 MX Orthopedics Corp Company Overview 70
  • 5.22 Nano Interface Technology LLC (Inactive) Company Overview 71
  • 5.23 OrthoGrid Systems Company Overview 72
  • 5.24 PreSRV Ltd. Company Overview 73
  • 5.25 Pro-Dex Inc Company Overview 74
  • 5.26 Renova Orthopedics, LLC Company Overview 75
  • 5.27 Rochester Institute of Technology Company Overview 76
  • 5.28 SINTEF Company Overview 77
  • 5.29 Smith & Nephew Plc Company Overview 78
  • 5.30 Stanford University Company Overview 79
  • 5.31 Stryker Corporation Company Overview 80
  • 5.32 University of Alberta Company Overview 82
  • 5.33 University of Auckland Company Overview 83
  • 5.34 University of South Florida Company Overview 84
  • 5.35 University of Warwick Company Overview 86
  • 5.36 X-NOV Company Overview 88
  • 5.37 Zimmer Biomet Holdings Inc Company Overview 89

6 Hip Reconstruction Devices - Recent Developments 94

  • 6.1 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 94
  • 6.2 Aug 31, 2017: Beijing Chunlizhengda Medical Instruments: Interim Results Announcement For The Six Months Ended 30 June 2017 94
  • 6.3 Aug 29, 2017: MicroPort Orthopedics Announces Launch of its Procotyl Prime Acetabular Cup System for Total Hip Replacement Surgery 97
  • 6.4 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 97
  • 6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 98
  • 6.6 Aug 11, 2017: Bonovo participated in the Chinese Medical Association of neurosurgery branch of the 16th academic conference 100
  • 6.7 Aug 09, 2017: Hip Innovation Technology Initiates Clinical Trial of its Novel Hip Replacement System for the Treatment of Total Hip Arthroplasty 100
  • 6.8 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 101
  • 6.9 Aug 08, 2017: Materialise Reports Second Quarter 2017 Results 101
  • 6.10 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 104
  • 6.11 Aug 05, 2017: Bonovo participated in the first session of the Great Wall Orthopedic Forum, the 14th Beijing Orthopedic Association (BOA) and the first Beijing - Shanghai Orthopedic Summit meeting 105
  • 6.12 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results 105
  • 6.13 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 107
  • 6.14 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 108
  • 6.15 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 108
  • 6.16 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 109
  • 6.17 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 110
  • 6.18 Jul 27, 2017: Stryker reports second quarter 2017 results 113
  • 6.19 Jul 27, 2017: Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue 114
  • 6.20 Jul 19, 2017: PathPartner Technology Contributes to Arthromeda's Successful Preclinical Study of Arthrosight-PS Hip Alignment Navigation System 115
  • 6.21 Jul 19, 2017: Mr. Stephen Ooi, Former Zimmer Executive, Newly Appointed as Independent Board Director of XinRong Medical 116
  • 6.22 Jul 18, 2017: Implanet Announces H1 2017 Revenue 116
  • 6.23 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 117
  • 6.24 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 118
  • 6.25 Jul 07, 2017: MicroPort OrthoRecon Hosts Hip Replacement Live Surgery Symposium 119
  • 6.26 Jul 06, 2017: Medacta Spine Delivers Strong Growth in Q1 2017 and Introduces Key New Products 119
  • 6.27 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 120
  • 6.28 Jun 26, 2017: Henry Ford Welcomes Three New Senior Executives 120
  • 6.29 Jun 22, 2017: Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems 121
  • 6.30 Jun 20, 2017: ConforMIS Announces FDA 510(k) Clearance for iTotal Hip System 122
  • 6.31 Jun 19, 2017: MicroPort OrthoRecon Hosts SuperPath Training Course 122
  • 6.32 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 123
  • 6.33 Jun 12, 2017: Alteon HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech 123
  • 6.34 Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update 124
  • 6.35 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 126
  • 6.36 Jun 02, 2017: MicroPort OrthoRecon Attends CAOS 2017 126
  • 6.37 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 127
  • 6.38 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 128
  • 6.39 May 23, 2017: Brainlab Chief Financial Officer Joseph Doyle to Retire 131
  • 6.40 May 15, 2017: Henry Ford Health System Welcomes New Lansing Based Government Affairs Manager 132
  • 6.41 May 15, 2017: Henry Ford Wyandotte Hospital Welcomes Two Top Leaders 132
  • 6.42 May 09, 2017: Materialise Reports First Quarter 2017 Results 133
  • 6.43 May 08, 2017: Stryker Orthopaedics 2016 Settlement Program reaches milestone 135
  • 6.44 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 135
  • 6.45 May 04, 2017: Orthofix International Reports First Quarter 2017 Financial Results 137
  • 6.46 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 138
  • 6.47 May 02, 2017: Brainlab Names New Member of Executive Board 140
  • 6.48 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 141
  • 6.49 Apr 25, 2017: Stryker reports first quarter 2017 results 142
  • 6.50 Apr 25, 2017: Exactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth 143
  • 6.51 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 144
  • 6.52 Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 144
  • 6.53 Apr 18, 2017: Implanet announces Q1 2017 revenue 145
  • 6.54 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 145
  • 6.55 Apr 03, 2017: Judge Awards $2 Million to Zimmer Hip Implant Plaintiff Represented by Osborne & Associates and McGinn, Carpenter, Montoya & Love 146
  • 6.56 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 147
  • 6.57 Mar 31, 2017: B. Braun continues its sales and earnings growth 148
  • 6.58 Mar 31, 2017: Beijing Chunlizhengda Medical: Annual results announcement for the year ended 31 December 2016 149
  • 6.59 Mar 30, 2017: Exactech New Scientific and Clinical Research Presented at 2017 Orthopaedic Research Society Annual Meeting 155
  • 6.60 Mar 29, 2017: OrthAlign Announces Milestone Achievement 60,000th Joint Arthroplasty Case 155
  • 6.61 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 156
  • 6.62 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 157
  • 6.63 Mar 20, 2017: MicroPort OrthoRecon Attends 5th CHS Annual Meeting 157
  • 6.64 Mar 15, 2017: DJO Global Announces FDA 510(K) Clearance for Exprt Revision Hip 158
  • 6.65 Mar 14, 2017: Corin launches Optimized Positioning System (OPS) for hip replacement at AAOS 159
  • 6.66 Mar 14, 2017: Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017 159
  • 6.67 Mar 14, 2017: Medacta Helps Hospitals and Surgeons Go "All In" on Outpatient Care 161
  • 6.68 Mar 13, 2017: OrthoGrid Systems Announces Mark J. Carrico as Director of Marketing 162
  • 6.69 Mar 09, 2017: John Masonis, MD to Educate on Direct Anterior Approach Hip Replacement Using OrthoGrid's HipGrid System at AAOS 2017 Annual Meeting 162
  • 6.70 Mar 07, 2017: Intellijoint Surgical Announces intellijoint HIP Anterior Application FDA Clearance 163
  • 6.71 Mar 06, 2017: MicroPort OrthoRecon Attends 2nd National Academic Conference in Enhanced Recovery After Arthroplasty 163
  • 6.72 Mar 01, 2017: OrthAlign Appoints Eric B. Timko As New Chief Executive Officer and Chairman of the Board 164
  • 6.73 Feb 27, 2017: Amedica Announces Results of Independent Femoral Head Wear Testing 164
  • 6.74 Feb 27, 2017: Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results 165
  • 6.75 Feb 22, 2017: Change in the B. Braun Management Board 166
  • 6.76 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 166
  • 6.77 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 169
  • 6.78 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 171
  • 6.79 Feb 10, 2017: New Jersey Stryker Hip Lawsuit Plaintiffs Seek Multi-County Designation for LFIT V40 Femoral Head Claims, Bernstein Liebhard Reports 173
  • 6.80 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 174
  • 6.81 Feb 09, 2017: Smith & Nephew: Directorate Change 179
  • 6.82 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 179
  • 6.83 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 180
  • 6.84 Feb 01, 2017: Medacta USA's Spine Division Begins 2017 with Key Appointment, Significant Growth 181
  • 6.85 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 181
  • 6.86 Jan 31, 2017: OrthAlign Continues Impressive Worldwide Growth in 2016, Including Milestone Achievement 56,000th Joint Arthroplasty Case 182
  • 6.87 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 183
  • 6.88 Jan 25, 2017: OrthAlign Announces FDA Clearance for Direct Anterior Approach HipAlign 184
  • 6.89 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 185
  • 6.90 Jan 18, 2017: Orthofix Announces Resolution of SEC Investigations 186
  • 6.91 Jan 17, 2017: US District Court Rules in Favor of CoorsTek Medical in Ceramic Hip Implant Lawsuit Clearing the Path for CeraSurf-p Ceramic Hip Implants in the US 187
  • 6.92 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 188
  • 6.93 Jan 17, 2017: Corin welcomes Elvio Gramignano 188
  • 6.94 Jan 16, 2017: Implanet Reports 2016 Sales Growth of +18% to €7.8 Million 189
  • 6.95 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 190
  • 6.96 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 190
  • 6.97 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 190
  • 6.98 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 192
  • 6.99 Jan 10, 2017: Orthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results 192
  • 6.100 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 193
  • 6.101 Dec 20, 2016: New England Baptist Hospital Chosen by General Electric as a National Center of Excellence for Hip and Knee Replacement 194
  • 6.102 Dec 19, 2016: Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems 194
  • 6.103 Dec 16, 2016: Greatbatch Medical Recalls Standard Offset Cup Impactor Used for Hip Joint Replacement due to Inadequate Sterilization 195
  • 6.104 Dec 14, 2016: National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures 196
  • 6.105 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 197
  • 6.106 Dec 13, 2016: Orthofix Announces Appointment of Alex Lukianov to Board of Directors 197
  • 6.107 Dec 09, 2016: Microport Orthopedics has issued a hazard alert for components used for metal-on-metal hip implant components 198
  • 6.108 Dec 07, 2016: Further Far East Contract Success For JRI Orthopaedics 198
  • 6.109 Dec 05, 2016: KYOCERA Medical Receives FDA 510(k) Clearance for Initia Total Hip System, Featuring BIOCERAM AZUL Ceramic Femoral Head 199
  • 6.110 Dec 01, 2016: Dallas Jury Returns $1 Billion-Plus Verdict in Defective DePuy Hip Implants Lawsuit 199
  • 6.111 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 200
  • 6.112 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 201
  • 6.113 Nov 22, 2016: Amedica appoints vice president of sales and marketing 204
  • 6.114 Nov 22, 2016: Amedica Announces New Sales Leadership and Provides Regulatory Updates 204
  • 6.115 Nov 17, 2016: New UK Business Manager Appointed At JRI Orthopaedics 205
  • 6.116 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 206
  • 6.117 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 206
  • 6.118 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 207
  • 6.119 Nov 14, 2016: First-ever functional, patient-specific hip replacement procedures performed in the USA 207
  • 6.120 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results 208
  • 6.121 Nov 09, 2016: Materialise Reports Third Quarter 2016 Results 209
  • 6.122 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 212
  • 6.123 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 213
  • 6.124 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 215
  • 6.125 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 216
  • 6.126 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 217
  • 6.127 Oct 27, 2016: Stryker reports third quarter 2016 results 219
  • 6.128 Oct 10, 2016: Northgate Public Services secures five year contract extension with the National Joint Registry 220
  • 6.129 Oct 10, 2016: Implanet Announces Q3 2016 Sales of €1.5 Million 221
  • 6.130 Oct 06, 2016: Amedica Provides Business Update 222
  • 6.131 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 223
  • 6.132 Oct 05, 2016: Amedica Announces Workforce Reduction 223

7 Appendix 224

  • 7.1 Methodology 224
  • 7.2 About GlobalData 227
  • 7.3 Contact Us 227
  • 7.4 Disclaimer 227

List of Tables

1.1 List of Tables

  • Table 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
  • Table 2: Hip Reconstruction Devices - Pipeline Products by Segment 14
  • Table 3: Hip Reconstruction Devices - Pipeline Products by Territory 15
  • Table 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
  • Table 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
  • Table 6: Hip Reconstruction Devices - Ongoing Clinical Trials 18
  • Table 7: Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development 19
  • Table 8: Hip Reconstruction Devices - Pipeline Products by Stage of Development 21
  • Table 9: 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 10: Truss Implant - Hip Procedures - Product Status 23
  • Table 11: Truss Implant - Hip Procedures - Product Description 23
  • Table 12: Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 13: Infinia Total Hip Implant II - Product Status 24
  • Table 14: Infinia Total Hip Implant II - Product Description 24
  • Table 15: Arthromeda Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 16: ArthroSight-PS - Product Status 25
  • Table 17: ArthroSight-PS - Product Description 25
  • Table 18: Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 19: MULTI-T64 - Product Status 26
  • Table 20: MULTI-T64 - Product Description 26
  • Table 21: MULTI-T66 - Product Status 27
  • Table 22: MULTI-T66 - Product Description 27
  • Table 23: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 24: JMM Total Hip System - Product Status 28
  • Table 25: JMM Total Hip System - Product Description 28
  • Table 26: Konknow Hip System - Product Status 29
  • Table 27: Konknow Hip System - Product Description 29
  • Table 28: ConforMIS Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 29: iTotal Hip System - Product Status 30
  • Table 30: iTotal Hip System - Product Description 30
  • Table 31: Corentec Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 32: Bencox ID Cemented Stem - Collarless - Product Status 31
  • Table 33: Bencox ID Cemented Stem - Collarless - Product Description 31
  • Table 34: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 35: Bone Preserving Hip Stem - Product Status 32
  • Table 36: Bone Preserving Hip Stem - Product Description 32
  • Table 37: DeltaMotion Hip System - Product Status 33
  • Table 38: DeltaMotion Hip System - Product Description 33
  • Table 39: Hip Resurfacing System - Product Status 33
  • Table 40: Hip Resurfacing System - Product Description 34
  • Table 41: New Poly Hip Bearing - Product Status 34
  • Table 42: New Poly Hip Bearing - Product Description 34
  • Table 43: Next Generation Hip System - Product Status 34
  • Table 44: Next Generation Hip System - Product Description 35
  • Table 45: DePuy Synthes Inc - Ongoing Clinical Trials Overview 36
  • Table 46: DeltaMotion Hip System - A Multi-center, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the DeltaMotion Cup System in Subjects Requiring a Total Hip Replacement 37
  • Table 47: DeltaMotion Hip System - RSA-Measured in Vivo Migration and Micromotion in the DePuy Tri-lock, Corail and Deltamotion Hip Replacement Components: A Single-blinded Randomised Control Trial 37
  • Table 48: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 49: Alteon Acetabular System - Product Status 38
  • Table 50: Alteon Acetabular System - Product Description 38
  • Table 51: Alteon HA System - Product Status 39
  • Table 52: Alteon HA System - Product Description 39
  • Table 53: Alteon Revision Modular System - Product Status 39
  • Table 54: Alteon Revision Modular System - Product Description 39
  • Table 55: Exactech GPS Hip System - Product Status 40
  • Table 56: Exactech GPS Hip System - Product Description 40
  • Table 57: Hip Revision System - Product Status 40
  • Table 58: Hip Revision System - Product Description 40
  • Table 59: HIP Wedge Stem - Product Status 41
  • Table 60: HIP Wedge Stem - Product Description 41
  • Table 61: Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 62: Flex-Able - Product Status 42
  • Table 63: Flex-Able - Product Description 42
  • Table 64: Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 65: MiHip System - Product Status 43
  • Table 66: MiHip System - Product Description 43
  • Table 67: Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 68: Enhanced Durability Resurfacing Endoprosthesis - Product Status 44
  • Table 69: Enhanced Durability Resurfacing Endoprosthesis - Product Description 44
  • Table 70: Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 71: HIT Hip Replacement System - Product Status 45
  • Table 72: HIT Hip Replacement System - Product Description 45
  • Table 73: Hip Innovation Technology LLC - Ongoing Clinical Trials Overview 46
  • Table 74: HIT Hip Replacement System - A Multi-center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty 47
  • Table 75: Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 76: Phoenix Re-Surf - Product Status 48
  • Table 77: Phoenix Re-Surf - Product Description 48
  • Table 78: Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 79: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Status 49
  • Table 80: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Description 49
  • Table 81: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Status 50
  • Table 82: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Description 50
  • Table 83: JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 84: Acetabular Cup Liner - Product Status 51
  • Table 85: Acetabular Cup Liner - Product Description 52
  • Table 86: Avanteon Hip System - Product Status 52
  • Table 87: Avanteon Hip System - Product Description 52
  • Table 88: Ceramic Femoral Head - Product Status 53
  • Table 89: Ceramic Femoral Head - Product Description 53
  • Table 90: Furlong Evolution - Product Status 53
  • Table 91: Furlong Evolution - Product Description 54
  • Table 92: Furlong H-A.C. Acetabular Cup - Product Status 54
  • Table 93: Furlong H-A.C. Acetabular Cup - Product Description 55
  • Table 94: Furlong H-A.C. Hemi-Arthroplasty System - Product Status 55
  • Table 95: Furlong H-A.C. Hemi-Arthroplasty System - Product Description 56
  • Table 96: Furlong H-A.C. Revision Hip Stem - Product Status 56
  • Table 97: Furlong H-A.C. Revision Hip Stem - Product Description 57
  • Table 98: Furlong H-A.C. THR System - Product Status 57
  • Table 99: Furlong H-A.C. THR System - Product Description 58
  • Table 100: Furlong Hemi-Arthroplasty System - Product Status 58
  • Table 101: Furlong Hemi-Arthroplasty System - Product Description 59
  • Table 102: Furlong Modular THR - Product Status 59
  • Table 103: Furlong Modular THR - Product Description 59
  • Table 104: Furlong Securus Femoral Revision System - Product Status 60
  • Table 105: Furlong Securus Femoral Revision System - Product Description 60
  • Table 106: JRI Orthopaedics Ltd - Ongoing Clinical Trials Overview 61
  • Table 107: Furlong Evolution - A Prospective Multicentre Clinical Surveillance Study to Evaluate The Stability, Efficacy and Safety of the Furlong Evolution Hip Stem in Primary Total Hip Arthroplasty 62
  • Table 108: Furlong Evolution - Ceramic-on-ceramic Bearings In Hip Replacement With Low Rates Of Wear And Are Increasingly Being Used In Young Adults 62
  • Table 109: Furlong Evolution - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty. A Comparative Study on Stability, Bone Remodelling and Patient Outcome 62
  • Table 110: Avanteon Hip System - Prospective, Open Label, Single Arm, Monocentric Clinical Study Intended to Observe Efficacy and Safety of the Aeon-shaft (Artificial Hip Joint), Fa. Brehm, in Patients with Osteoarthritis of the Hip or a Fracture of the Femoral Neck 63
  • Table 111: KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 112: Aquala Liner - Product Status 64
  • Table 113: Aquala Liner - Product Description 64
  • Table 114: Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 115: DELTA-ONE-TT - Product Status 65
  • Table 116: DELTA-ONE-TT - Product Description 65
  • Table 117: DELTA-Revision TT - Product Status 66
  • Table 118: DELTA-Revision TT - Product Description 66
  • Table 119: Metalicity Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 120: M-COR Primary Press-Fit - Product Status 67
  • Table 121: M-COR Primary Press-Fit - Product Description 67
  • Table 122: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 123: Anterior Approach THA Instrument - Product Status 68
  • Table 124: Anterior Approach THA Instrument - Product Description 68
  • Table 125: Next Generation Optimized ML Taper Hip Stem - Product Status 69
  • Table 126: Next Generation Optimized ML Taper Hip Stem - Product Description 69
  • Table 127: XL & E-POLY BIOFOAM - Product Status 69
  • Table 128: XL & E-POLY BIOFOAM - Product Description 69
  • Table 129: MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 130: Shape Memory Alloy Hip Implant - Product Status 70
  • Table 131: Shape Memory Alloy Hip Implant - Product Description 70
  • Table 132: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 133: Hip Implant - Product Status 71
  • Table 134: Hip Implant - Product Description 71
  • Table 135: OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 136: HipFXGrid - Product Status 72
  • Table 137: HipFXGrid - Product Description 72
  • Table 138: PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 139: Atlas Femoral Head Preserving Prosthesis - Product Status 73
  • Table 140: Atlas Femoral Head Preserving Prosthesis - Product Description 73
  • Table 141: Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 142: Acetabular Cup Revision Tool - Product Status 74
  • Table 143: Acetabular Cup Revision Tool - Product Description 74
  • Table 144: Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 145: A-FX Hip Fracture System - Product Status 75
  • Table 146: A-FX Hip Fracture System - Product Description 75
  • Table 147: Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 148: Artificial Hip Joint - Product Status 76
  • Table 149: Artificial Hip Joint - Product Description 76
  • Table 150: SINTEF Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 151: Smart Hip Prosthesis - Product Status 77
  • Table 152: Smart Hip Prosthesis - Product Description 77
  • Table 153: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 154: Navio Total Hip Arthroplasty System - Product Status 78
  • Table 155: Navio Total Hip Arthroplasty System - Product Description 78
  • Table 156: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 157: Avascular Necrosis Implant - Product Status 79
  • Table 158: Avascular Necrosis Implant - Product Description 79
  • Table 159: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 160: Hip Distraction Device - Product Status 80
  • Table 161: Hip Distraction Device - Product Description 80
  • Table 162: MITCH TRH System - Product Status 81
  • Table 163: MITCH TRH System - Product Description 81
  • Table 164: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 165: Hip Replacement And Bone Loss Monitor - Product Status 82
  • Table 166: Hip Replacement And Bone Loss Monitor - Product Description 82
  • Table 167: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 168: Acetabular Reconstruction Implant - Product Status 83
  • Table 169: Acetabular Reconstruction Implant - Product Description 83
  • Table 170: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 171: Cannulated Screw Jig - Product Status 84
  • Table 172: Cannulated Screw Jig - Product Description 84
  • Table 173: Injectable Hip Hemiarthroplasty Device - Product Status 85
  • Table 174: Injectable Hip Hemiarthroplasty Device - Product Description 85
  • Table 175: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 176: Femoral Head Positioning Device - Product Status 86
  • Table 177: Femoral Head Positioning Device - Product Description 86
  • Table 178: Hip Prostheses - Product Status 87
  • Table 179: Hip Prostheses - Product Description 87
  • Table 180: X-NOV Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 181: Mobipop - Product Status 88
  • Table 182: Mobipop - Product Description 88
  • Table 183: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 184: Durom Full Resurfacing Hip - Product Status 89
  • Table 185: Durom Full Resurfacing Hip - Product Description 90
  • Table 186: E1 Avantage Hip Cup - Product Status 90
  • Table 187: E1 Avantage Hip Cup - Product Description 90
  • Table 188: ReCap Total Hip Resurfacing System - Product Status 91
  • Table 189: ReCap Total Hip Resurfacing System - Product Description 91
  • Table 190: Zimmer Biomet Holdings Inc - Ongoing Clinical Trials Overview 92
  • Table 191: E1 Avantage Hip Cup - Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis 93
  • Table 192: E1 Avantage Hip Cup - RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes 93
  • Table 193: Glossary 226

List of Figures

1.2 List of Figures

  • Figure 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
  • Figure 2: Hip Reconstruction Devices - Pipeline Products by Segment 14
  • Figure 3: Hip Reconstruction Devices - Pipeline Products by Territory 15
  • Figure 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
  • Figure 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
  • Figure 6: Hip Reconstruction Devices - Ongoing Clinical Trials 18
Back to Top